This document discusses convergence insufficiency (CI), a binocular vision problem characterized by an inability to converge the eyes or sustain convergence. CI causes symptoms like headaches, eye strain, and blurred vision during close work. The document summarizes a clinical trial finding that office-based vision therapy is an effective treatment for CI, improving symptoms and convergence measures, while home exercises and placebo therapy were less effective. It encourages optometrists to screen for CI using tests like near point of convergence, recognize symptoms, and inform patients that vision therapy can effectively treat this common problem.
3. Introduction
What is convergence insufficiency?
A sensory and neuromuscular anomaly of
binocular vision system, characterized by an
inability to converge the eyes or sustain
convergence.
CI=Abnormally poor convergence amplitude
Convergence insufficiency is a binocular
vision problem…but it is NOT strabismus
4. Symptoms
Symptoms associated with close work:
Asthenopia= Symptoms related to the effort to
maintain BSV
Headaches,
Intermittent blur vision
Inability to sustain and concentrate
Discomfort of the eyes (burning,tearing) and
etc.
5.
6. Convergence insufficiency is
routinely missed in vision screening
Why???
CI patients routinely have 6/6
Children with CI may not complain about their eyes to
their parents or tell the family physician
Most CI patients have “quality of life” symptoms which
are over looked in routine screenings
7. Facts about CI
A disease that affects over 21 million in the
United States
Massive research effort over 10 years by the
CITT Group
Latest study (2008) NEI funded $6.1 M.
multicenter including: The Mayo Clinic, Bascom
Palmer and 6 Colleges of Optometry around the
US.
Can cause behaviors that appear to be
ADD/ADHD, reading and learning problems
There is a cure!
10. Objective:
To compare vision therapy /orthoptics,
pencil push-ups, and placebo vision
therapy/ orthoptics as treatments for
symptomatic convergence insufficiency in
children 9 to 18 years of age.
11. Methods:
In a randomized, multicenter clinical trial,
47 children 9 to 18 years of age with
symptomatic CI were randomly assign to
received 12 weeks of:-
Office-based vision therapy/orthoptics
Office-based placebo vision
therapy/orthoptics
Home-based pencil push-ups therapy.
12. Main outcome measures:
1. The primary outcome
a. Measure was the symptom score on the
Convergence Insufficiency Symptom Survey
(CISS)
2. The secondary outcome
a. Measures were the near point of
convergence (NPC) and positive fusional
vergence (PFV) at near.
13.
14. What to test?
Near Point of Convergence (NPC)
The (NPC) is measured by bringing the
test target to the nose and observing when
the patient sees double, or one eye
deviates out.
NPC ( receded 5cm or recovery greater
than 7cm)
15. How to test NPC?
Penlight Red/Green- Near Point of
Convergence Test (PLRG NPC) for screening
16.
17. Results:
Groups
Mean symptom score decreased
Statistically Clinically
Office-based vision
therapy/orthoptics (32.1 to 9.5)
NPC (from 13.7cm to
4.5cm; p<0.001)
PFV (from 12.5PD to
31.8PD; p<0.001).
Office-based placebo
vision therapy/orthoptics (30.7 to 24.2)
X
Home-based pencil
push-ups therapy (29.3 to 25.9)
X
Symptoms, which were similar in all groups at baseline, and after the
treatment:-
**only patients in the office-based vision therapy/orthoptics group demonstrated
both clinically and statistically significant changes for the NPC and PFV at near.
18. Discussion
In this study, office based vision therapy/orthoptics was
the only treatment that produced clinically significant
improvements in the near point of convergence and
positive fusional vergence.
However, over half of the patients in this group (58%)
were still symptomatic at the end of treatment, although
their symptoms were significantly reduced.
All three groups demonstrated statistically significant
changes in symptoms with:-
42% in office-based vision therapy/orthoptics,
31% in office-based placebo vision therapy/orthoptics, and
20% in home-based pencil push-ups meeting our criteria for
elimination of symptoms.
20. Results:
Groups Successful rate
In-office and home
therapy
61.9%
Home therapy only 30%
Control group (placebo) 10.5%
-Vision therapy is effective in eliminating asthenopia
and improving convergence function in adult patients.
- Combination in-office and home therapy tends to
produce better results than does home therapy alone.
21. Conclusions
o Office-based vergence accommodative therapy is an
effective treatment for children and adults with
symptomatic convergence insufficiency.
o Although among children they might experienced
symptomatic CI at the end of the treatment, but the
recurrence rate is about a year (89%, no significant
differences between group with p=0.26).
o The combination treatment in-office vision therapy and
home based therapy are the best solution among adults
with CI.
24. 2. Recognize
Recognize the symptoms
Avoids near centered visual tasks like reading
Eyes hurt or strain with sustained reading
Headaches associated with sustained reading
Words have illusory movement or overlap (double) when reading
Diagnose receded NPC
25. 3. Inform
Provide CI literature
Advise further
diagnostic evaluation
Prescribe treatment
**Point to ponder
Optometric Vision Therapy IS NOT eye exercises!!
Vision Therapy is rehabilitation treatment of the visual
brain with proven applications in neuroscience
27. Conclusion
Convergence insufficiency is a sensory and
neuromuscular anomaly of binocular vision
system, characterized by an inability to
converge the eyes or sustain convergence.
Office-based vision therapy utilizes principles
of neuroscience research:-
1. Visual awareness
2. Feedback
3. Loading -Action, movement and relevance
29. References
Convergence Insufficiency Treatment Trial Study Group. Randomized clinical trial
of treatments for symptomatic convergence insufficiency in children. Arch
Ophthalmol. 2008 Oct;126(10):1336-49.
Barnhardt C, Cotter SA, Mitchell GL, Scheiman M, Kulp MT; CITT Study Group.
Symptoms in children with convergence insufficiency: before and after
treatment. Optom Vis Sci. 2012 Oct;89(10):1512-20.
Scheiman M, Kulp MT, Cotter S, Mitchell GL, Gallaway M, Boas M, Coulter R,
Hopkins K, Tamkins S; Convergence Insufficiency Treatment Trial Study
Group. Vision therapy/orthoptics for symptomatic convergence insufficiency in
children: treatment kinetics. Optom Vis Sci. 2010 Aug;87(8):593-603.
Rouse M, Borsting E, Mitchell GL, Kulp MT, Scheiman M, Amster D, Coulter R,
Fecho G, Gallaway M; CITT Study Group. Academic behaviors in children with
convergence insufficiency with and without parent-reported ADHD. Optom Vis
Sci. 2009 Oct;86(10):1169-77.
Convergence Insufficiency Treatment Trial Study Group. Long-term effectiveness
of treatments for symptomatic convergence insufficiency in children. Optom Vis
Sci. 2009 Sep;86(9):1096-103.
Kulp M, Mitchell GL, Borsting E, Scheiman M, Cotter S, Rouse M, Tamkins S,
Mohney BG, Toole A, Reuter K; Convergence Insufficiency Treatment Trial
Study Group. Effectiveness of placebo therapy for maintaining masking in a